×
Veracyte Receivables 2012-2025 | VCYT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Veracyte receivables from 2012 to 2025. Receivables can be defined as the total amount of collectibles for a company
View More
Veracyte Receivables 2012-2025 | VCYT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Veracyte receivables from 2012 to 2025. Receivables can be defined as the total amount of collectibles for a company
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$186.1B
Intuitive Surgical (ISRG)
$169.7B
IDEXX Laboratories (IDXX)
$51.8B
Edwards Lifesciences (EW)
$47.8B
Alcon (ALC)
$39.4B
IQVIA Holdings (IQV)
$32.4B
DexCom (DXCM)
$29.5B
Mettler-Toledo (MTD)
$26.8B
STERIS (STE)
$24.1B
Waters (WAT)
$18B
SONOVA HOLDING (SONVY)
$17.4B
Hologic (HOLX)
$14.9B
Penumbra (PEN)
$10.6B
Globus Medical (GMED)
$8.3B
Sysmex ADR (SSMXY)
$7.9B
Masimo (MASI)
$7.6B
Teleflex (TFX)
$5.6B
Glaukos (GKOS)
$5.5B
TransMedics (TMDX)
$3.9B
Integer Holdings (ITGR)
$3.8B
LivaNova (LIVN)
$3.1B
Alphatec Holdings (ATEC)
$2.4B
PROCEPT BioRobotics (PRCT)
$2.2B
Artivion (AORT)
$2.1B
Nihon Kohden (NHNKY)
$2B
Elekta AB (EKTAY)
$1.8B
Integra LifeSciences Holdings (IART)
$1.2B
Paragon 28 (FNA)
$1.1B
OPKO Health (OPK)
$1.1B
Pulse Biosciences (PLSE)
$1B